|
covid-19 |
11 |
|
sars-cov-2 |
11 |
|
h7n9 |
9 |
|
influenza a virus |
9 |
|
faci |
8 |
|
betacoronavirus |
7 |
|
cell line |
7 |
|
coronavirus infection |
7 |
|
enzyme activation |
7 |
|
human |
7 |
|
inflammasome |
7 |
|
live attenuated vaccine |
7 |
|
nsp16 |
6 |
|
orf3a |
6 |
|
sterilising immunity |
6 |
|
aim2 |
5 |
|
antiviral response |
5 |
|
avian influenza a virus |
5 |
|
calcineurin |
5 |
|
cccdna |
5 |
|
cholesterol uptake |
5 |
|
clathrin adaptors |
5 |
|
ddx5 |
5 |
|
endocytosis |
5 |
|
h5n1 |
5 |
|
h7n9 virus |
5 |
|
hbx |
5 |
|
hepatitis b virus |
5 |
|
hypercholesterolemia |
5 |
|
ifi16 |
5 |
|
inflammasome activation |
5 |
|
innate antiviral response |
5 |
|
keywords sars-cov-2 |
5 |
|
low-density lipoprotein receptor |
5 |
|
mavs |
5 |
|
metabolic syndrome |
5 |
|
mitochondria |
5 |
|
nfat |
5 |
|
nlrp3 |
5 |
|
ns5 protein |
5 |
|
nsp1 |
5 |
|
pa |
5 |
|
pb1 |
5 |
|
pb1-f2 virulence factor |
5 |
|
pb2 |
5 |
|
rcan3 |
5 |
|
rig-i |
5 |
|
sirt1 |
5 |
|
sirtuin |
5 |
|
stat1 |
5 |
|
stat2 |
5 |
|
transcript isoform |
5 |
|
transfection |
5 |
|
type ii interferon |
5 |
|
wireless sensor networks |
5 |
|
zika virus |
5 |
|
animal reservoir |
4 |
|
antivirals |
4 |
|
bats |
4 |
|
bzip transcription factors |
4 |
|
cell membrane - drug effects - metabolism |
4 |
|
cgas |
4 |
|
coronavirus |
4 |
|
creb-h |
4 |
|
cyclic amp response element-binding protein - chemistry - genetics - metabolism |
4 |
|
endemic |
4 |
|
endoplasmic reticulum |
4 |
|
liver-enriched transcription factors |
4 |
|
membrane-bound transcription factors |
4 |
|
mers-cov |
4 |
|
mitochondrial dna release |
4 |
|
n-linked glycosylation |
4 |
|
nf-κb |
4 |
|
pandemic |
4 |
|
pb1-f2 |
4 |
|
protein processing, post-translational - drug effects |
4 |
|
regulated intramembrane proteolysis |
4 |
|
replicon |
4 |
|
sars-cov |
4 |
|
single-cycle infectious virus |
4 |
|
sting |
4 |
|
transcription, genetic - drug effects |
4 |
|
transcriptional activation - drug effects |
4 |
|
unfolded protein response |
4 |
|
vaccines |
4 |
|
2019 novel coronavirus |
3 |
|
2019 novel coronavirus (2019-ncov) |
3 |
|
adeno-associated virus |
3 |
|
adult t-cell leukemia |
3 |
|
crispr/cas9 |
3 |
|
cure of epstein–barr virus infection |
3 |
|
ebna1 |
3 |
|
episomal viral dna genome |
3 |
|
epstein-barr virus |
3 |
|
epstein–barr virus |
3 |
|
genetic analysis of epstein–barr virus |
3 |
|
hbz |
3 |
|
high-fat diet |
3 |
|
human t-cell leukemia virus type 1 |
3 |
|
humanized mouse model |
3 |
|
inflammation |
3 |
|
nasopharyngeal carcinoma |
3 |
|
novel coronavirus pneumonia (ncp) |
3 |
|
pact |
3 |
|
rna-guided genome editing |
3 |
|
tax |
3 |
|
type i ifns |
3 |
|
type i interferons |
3 |
|
cgref1 |
2 |
|
communicable diseases biology |
2 |
|
creb |
2 |
|
creb-h transcription factor |
2 |
|
crtc1 |
2 |
|
diabetes |
2 |
|
gluconeogenesis |
2 |
|
glycosylation. |
2 |
|
hepatokine |
2 |
|
mda5 |
2 |
|
medical sciences |
2 |
|
metabolic dysfunction-associated steatotic liver disease (masld) |
2 |
|
microbiology |
2 |
|
nod-like receptors |
2 |
|
rfwd2 |
2 |
|
rig-i-like receptors |
2 |
|
sik1 |
2 |
|
transcription factors. |
2 |
|
ubiquitination |
2 |
